CEBPD 调节氧化应激和炎症反应 在高血压心脏重塑中
Jinghong Zhao1, Jilin Hu, Rongyi Zhang
1Department of Cardiology, Nanchong Central Hospital, Nanchong, China.
Shock (Augusta, Ga.)
|September 26, 2023
概括
通过降低氧化应激和炎症,CCAAT/增强剂结合蛋白三角 (CEBPD) 的上调减轻高血压心脏重塑. CEBPD促进了miR-96-5p,它抑制了内醇1,4,5-三酸盐受体1 (IP3R),以保护心脏.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞生理学 细胞生理学
背景情况:
- 高血压是心脏重塑和死亡的主要原因.
- 基础高血压心脏改造的分子机制,特别是氧化应激和炎症,需要进一步阐明.
研究的目的:
- 研究CCAAT/增强剂结合蛋白三角 (CEBPD) 在高血压心脏重塑中的作用.
- 探索涉及CEBPD,miR-96-5p和内醇1,4,5-三酸盐受体1 (IP3R) 调节氧化应激和炎症的分子途径.
主要方法:
- 通过注射 ангиотензин-II 建立了使用高血压的小鼠模型.
- 使用体内和体外模型与CEBPD过度表达来评估心脏功能,组织学变化,细胞活力,氧化应激标志物和炎症因素.
- 经过验证的分子相互作用使用促进剂丰富,化酶试验和基因沉默/过度表达实验.
主要成果:
- 在高血压心脏组织中,CEBPD水平下降.
- 对CEBPD的升调改善了心脏功能,减轻了心脏纤维化和缩,并减少了氧化应激和炎症标志物 (ROS,LDH,MDA,TNF-α,IL-1β,IL-6).
- CEBPD促进了miR-96-5p的表达,这反过来又对IP3R进行了负面调节. 沉默miR-96-5p或过度表达IP3R可以逆转CEBPD的保护作用.
结论:
- 在高血压心脏重塑过程中,CEBPD起着保护作用.
- CEBPD/miR-96-5p/IP3R轴抑制氧化应激和炎症,从而减轻心脏重塑.
- 针对CEBPD途径可能为高血压引起的心脏病提供治疗策略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
110
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
110
Psychoneuroimmunology: Cardiovascular Disease
46
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
46


